BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20854471)

  • 1. Expression of ezrin, Bcl-2, and Ki-67 in chondrosarcomas.
    Söderström M; Palokangas T; Vahlberg T; Böhling T; Aro H; Carpen O
    APMIS; 2010 Oct; 118(10):769-76. PubMed ID: 20854471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in prostate cancer: bax correlation with stage.
    Amirghofran Z; Monabati A; Gholijani N
    Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
    Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
    Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.
    Sarrió D; Rodríguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J
    Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
    Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
    Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma.
    Su JS; Arima K; Hasegawa M; Franco OE; Yanagawa M; Sugimura Y; Kawamura J
    Hinyokika Kiyo; 2003 Nov; 49(11):649-58. PubMed ID: 14719452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].
    Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Bcl-2 family proteins in psoriasis.
    Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
    Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas.
    Xie X; Clausen OP; Boysen M
    Laryngoscope; 2004 Oct; 114(10):1785-90. PubMed ID: 15454773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
    Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
    Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.